GenomeQuest, a US-based provider of sequence data management (SDM) products, has announced a strategic partnership with Pathogenica to offer discovery services in infectious disease research, including the interaction between the human microbiome and human genome.
This partnership combines Pathogenica's technology for detecting and sub-selecting pathogen genomes in human tissue with GenomeQuest's large-scale whole genome, exome, and microbiome analysis.
The target applications span basic research through clinical trial endpoint evaluation and focus on infection therapeutics in which both the pathogen genotype and the human genotype influence the treatment outcome. This will enable pharmaceutical companies to rapidly examine combined pathogen/host genetics in thousands of human infectious disease samples.
The companies will immediately begin collaboration on target selection, assay customisation, and validation studies.
Search for more infectious disease research related information
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
